ESAT NAMAL, ÖZGÜL PAMUKÇU CERCİZ, EMEL GÖKMEN
Turkish Journal of Oncology - 2016;31(2):51-54
While multiple primary tumors are rarely reported in literature, we expect that it will be seen more often in the future as a result of improvements in diagnosis and treatment of cancer. Molecular targeted therapies are promising modalities that are now used more commonly. Presently described is oncological response for a 70-year-old women with multiple primary cancers - breast and lung - in which 2 targeted therapies were administered. While there is currently no standard therapy in the literature for multiple primary cancers, it is the authors’ suggestion that targeted therapies may be a promising choice for these cases.
